Beckman Coulter Access CK-MB (CLIA)

Product Description

Brand	Beckman Coulter
Sample Type	Serum/ Plasma
Pack Size	2 x 50T
CAT No.	386371
Application	Tumor Marker

Beckman Coulter Access CK-MB (CLIA) is a high-performance Chemiluminescent Immunoassay (CLIA) reagent designed for the quantitative determination of Creatine Kinase-MB (CK-MB) in human serum and plasma. The Access CK-MB CLIA Reagent delivers high sensitivity, excellent specificity, rapid turnaround time, and reliable quantitative results, making it an ideal choice for hospitals, cardiac care centers, emergency departments, diagnostic laboratories, and reference laboratories.

Advanced Chemiluminescence Technology

Built on Chemiluminescence Immunoassay (CLIA) principles, this analyzer ensures high sensitivity and specificity in detecting CK-MB, supporting critical diagnostics in laboratory environments. The system automates the detection process, minimizing user intervention and the risk of human error.


Portability and Real-Time Results

Despite its precision and advanced functionality, the BC Access CK-MB (CLIA) features a portable design, enabling easy relocation within laboratories. Real-time operation enhances workflow by providing immediate results, which is crucial for timely clinical decisions in cardiac care.


Optimal Storage and User-Friendly Design

Components and reagents should be stored between 2 to 10C to sustain product efficacy. The analyzer's automatic operating type and straightforward interface reduce training time and streamline daily laboratory procedures, ensuring reliable use by staff at all experience levels.